- Home
- MYGN vs HPK Comparison
MYGN vs HPK Comparison
Compare MYGN & HPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- HPK
- Stock Information
- Founded
- MYGN 1991
- HPK 2019
- Country
- MYGN United States
- HPK United States
- Employees
- MYGN N/A
- HPK N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- HPK Oil & Gas Production
- Sector
- MYGN Health Care
- HPK Energy
- Exchange
- MYGN Nasdaq
- HPK Nasdaq
- Market Cap
- MYGN 2.0B
- HPK 1.6B
- IPO Year
- MYGN 1995
- HPK N/A
- Fundamental
- Price
- MYGN $13.36
- HPK $14.02
- Analyst Decision
- MYGN Hold
- HPK Hold
- Analyst Count
- MYGN 12
- HPK 1
- Target Price
- MYGN $23.92
- HPK $14.00
- AVG Volume (30 Days)
- MYGN 942.4K
- HPK 259.8K
- Earning Date
- MYGN 11-07-2024
- HPK 11-04-2024
- Dividend Yield
- MYGN N/A
- HPK 1.14%
- EPS Growth
- MYGN N/A
- HPK N/A
- EPS
- MYGN N/A
- HPK 1.26
- Revenue
- MYGN $823,600,000.00
- HPK $1,135,761,000.00
- Revenue This Year
- MYGN $13.82
- HPK N/A
- Revenue Next Year
- MYGN $4.59
- HPK N/A
- P/E Ratio
- MYGN N/A
- HPK $11.15
- Revenue Growth
- MYGN 12.15
- HPK 6.34
- 52 Week Low
- MYGN $12.87
- HPK $12.47
- 52 Week High
- MYGN $29.30
- HPK $17.48
- Technical
- Relative Strength Index (RSI)
- MYGN 26.22
- HPK 43.84
- Support Level
- MYGN $12.87
- HPK $13.70
- Resistance Level
- MYGN $15.44
- HPK $14.76
- Average True Range (ATR)
- MYGN 0.84
- HPK 0.49
- MACD
- MYGN -0.02
- HPK -0.09
- Stochastic Oscillator
- MYGN 12.37
- HPK 16.77
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
About HPK HighPeak Energy Inc.
HighPeak Energy Inc is an independent oil and natural gas company focused on the development of unconventional oil and natural gas reserves in Howard County of the Midland Basin. The company operates in a single segment, which is oil and natural gas development, exploration, and production.